As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient ...

SK Life Science launched its latest DTC advertising campaign for its seizure medication. 1 Road to Reduction is an ...

Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil ...

Clearance of ASC50 paves the way for a Phase I trial in patients with mild-to-moderate plaque psoriasis.

Lilly is also developing oral therapies for its gastroenterology pipeline.

The FDA has approved Roche’s Susvimo (ranibizumab injection) 100 mg/mL for treating patients with diabetic retinopathy (DR).

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

Deal includes VG-3927, a first-in-class TREM2 agonist aimed at advancing next-generation Alzheimer disease therapies.

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses the company's nationwide push to reduce cardiovascular risk ...

The film tells the story of a family impacted by the disease and shares the importance of checking to make sure that children ...

PE: How can digital solutions address gaps in women’s healthcare? Partridge: Digital solutions play a crucial role in ...